Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes

Full Thickness Macular Hole Clinical Trial

Official title:
Vitrectomy and Inverted Flap or Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes

Status Recruiting

Clinical Trial Summary

Primary outcome: difference of microperimetry retinal sensitivity after primary vitrectomy for idiopathic full thickness macular holes with inverted flap technique versus internal limiting membrane (ILM) peeling technique Secondary outcomes: difference of visual change after primary vitrectomy for idiopathic full thickness macular holes with inverted flap technique versus internal limiting membrane (ILM) peeling technique; difference in closure rate after primary vitrectomy for idiopathic full thickness macular holes with inverted flap technique versus internal limiting membrane (ILM) peeling technique

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04498624
Study type	Interventional
Source	University of Turin, Italy
Contact	MIchele Reibaldi, MD
Phone	0116331863
Email	michele.reibaldi@unito.it
Status	Recruiting
Phase	N/A
Start date	May 1, 2020
Completion date	May 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed	`NCT01020760` - Protocol for RCT of Posturing in Phacovitrectomy for Full Thickness Macular Hole (FTMH)	N/A
Completed	`NCT05897671` - Foveal Sparing ILM Peeling With ILM Flap Transposition
Completed	`NCT01226160` - Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole	Phase 0
Recruiting	`NCT05828251` - Full Thickness Macular Hole; Should it be Handled Subacutely?	N/A